Skip to main content
Jose Lutzky, MD, Oncology, Miami, FL, UMHC - Sylvester Comprehensive

JoseLutzkyMDFACP

Oncology Miami, FL

Melanoma

Director, Cutaneous Oncology - Sylvester Comprehensive Cancer Center.

Dr. Lutzky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lutzky's full profile

Already have an account?

Summary

  • Jose Lutzky, M.D., is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Lutzky works as part of a multidisciplinary team of cancer experts and researchers. He earned his medical degree from Universida de Federal do Rio Grande do Sul. Dr. Lutzky is fluent in Spanish and Portuguese.

Clinical Expertise

  • Melanoma and cutaneous malignancies

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1985 - 1988
  • Mount Sinai Medical Center of Florida
    Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 1982 - 1985
  • Federal University of Rio Grande do Sul School of Medicine
    Federal University of Rio Grande do Sul School of MedicineClass of 1980

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1984 - 2026
  • CA State Medical License
    CA State Medical License 1989 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2020
  • America's Top Doctors for Cancer Castle Connolly, 2020
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma  
    Igor Puzanov, Kim A Margolin, Jose Lutzky, Ahmad Tarhini, Nageatte Ibrahim, JAMA Oncology

Authored Content

  • Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
  • Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020

Press Mentions

  • Northwest Biotherapeutics: Data Is Done, Just Wait for Approval
    Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
  • New Immunotherapy Drug Combo Approved for Metastatic Melanoma
    New Immunotherapy Drug Combo Approved for Metastatic MelanomaApril 11th, 2022
  • Watch Out for Those Tanning Beds — They’re Linked to Skin Cancer
    Watch Out for Those Tanning Beds — They’re Linked to Skin CancerMay 27th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations